Rare diseases
Investigational molecules
Locations
Back to Slovakia44 clinical trials in Svidnik, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
SlovakiaStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
SlovakiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
SlovakiaStudy of ISIS 678354 for Patients with Severe High Triglycerides
SlovakiaStudy on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers
SlovakiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
SlovakiaStudy Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines
SlovakiaStudy of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
SlovakiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
SlovakiaStudy of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels
SlovakiaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
SlovakiaStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on heart failure prevention and innovative treatments for atherosclerotic cardiovascular disease. Research includes evaluation of new therapeutic combinations and interventions for improving patient outcomes.
Multiple trials investigating novel compounds for reducing major adverse cardiovascular events.
Comprehensive research into chronic skin conditions, particularly hidradenitis suppurativa and chronic spontaneous urticaria. Studies evaluate both established and experimental treatments.
Clinical trials focusing on long-term management and innovative therapeutic approaches.
Studies addressing severe hypertriglyceridemia and related metabolic conditions. Research aims to evaluate new treatments for managing lipid disorders and associated cardiovascular risks.
Innovative approaches to treating complex metabolic disorders with novel therapeutic agents.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
